Biocon trades in fine fettle for second consecutive session

19 Dec 2013 Evaluate

Biocon is currently trading at Rs. 443.65, up by 6.30 points or 1.44 % from its previous closing of Rs. 437.35 on the BSE.

The scrip opened at Rs. 441.90 and has touched a high and low of Rs. 446.00 and Rs. 432.00 respectively. So far 184199 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 450.90 on 18-Dec-2013 and a 52 week low of Rs. 255.00 on 04-Mar-2013.

Last one week high and low of the scrip stood at Rs. 450.90 and Rs. 378.85 respectively. The current market cap of the company is Rs. 8878.00 crore.

The promoters holding in the company stood at 60.97% while Institutions and Non-Institutions held 18.06% and 20.97% respectively.

Biocon, Asiais premier biotechnology company, and Quark Pharmaceuticals, Inc, a world leader in the discovery and development of siRNA -based therapeutics, have entered into a Licensing & Collaboration agreement for the development of a range of siRNA (small interfering RNA) based novel therapeutics.

This collaboration will enable Biocon to co-develop, manufacture & commercialize QPI-1007, a novel siRNA drug candidate for ophthalmic conditions, for India and other key markets. Biocon will have access to Quark's innovative and proprietary siRNA technology platform that can be leveraged for the development of novel therapeutics for various unmet medical needs.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services

Biocon Share Price

377.55 -1.50 (-0.40%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×